Safety and efficacy of unmodified whole blood vs. buffy coat-depleted red cell concentrates in autologous transfusion of elective orthopaedic surgery patients

Transfusion Medicine

Volumn 14, Issue 5, 2004, Pages 347-358

  Karger, Ralf ^a,b   Stangenberg, K ^a   Hinrichs, F ^a   Griss, P ^a   Kretschmer, V ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

Autologous transfusion; Elective orthopaedic surgery; Preoperative autologous blood donation; Red cell concentrates; Transfusion related immunomodulation; Whole blood transfusion

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; BLOOD AUTOTRANSFUSION; BLOOD DONOR; BLOOD STORAGE; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; ELECTIVE SURGERY; ERYTHROCYTE CONCENTRATE; FEMALE; HUMAN; IMMUNOMODULATION; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; ORTHOPEDIC SURGERY; OUTCOMES RESEARCH; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDY; SAFETY;

EID: 8144228620     PISSN: 09587578     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0958-7578.2004.00526.x     Document Type: Article

References (29)

1. Avail, A., Hyllner, M., Bengtson, J.P., Carlsson, L. & Bengtsson, A. (1997) Postoperative inflammatory response after autologous and allogeneic blood transfusion. Anesthesiology, 87, 511-516.
2. Bundesärztekammer. (2000) Directives for the procurement of blood constituents and the application of blood products (haemotherapy) (German). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, 43, 555-589.
3. Council of Europe. (2002) Guide to the Preparation, Use and Quality Assurance of Blood Components, 8 edn. Council of Europe Publishing, Strasbourg Cedex.
4. Deutsche Gesellschaft für Transfusionsmedizin und Immunhämatologie, Deutsche Gesellschaft für Anaesthesiologie und Intensivmedizin, Berufsverband deutscher Anaesthesisten & Berufsverband der Deutschen Chirurgen. (1994) Additional recommendations to the directives for blood group serology and blood transfusion of the Federal Chamber of Physicians concerning autologous blood donation and transfusion (German). Anaesthesie und Intensivmedizin, 35, 82.
5. Etchason, J., Petz, L., Keeler, E., Calhoun, L., Kleinman, S., Snider, C., Fink, A. & Brook, R. (1995) The cost-effectiveness of preoperative autologous blood donation. The New England Journal of Medicine, 332, 719-724.
6. Fergusson, D., Aaron, S.D., Gyatt, G. & Hébert, P. (2002a) Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis. British Medical Journal, 325, 652-654.
7. Fergusson, D., Hebert, P. & Shapiro, S. (2002b) The before/after study design in transfusion medicine: methodologic considerations. Transfusion Medicine Reviews, 16, 296-303.
8. Fernandez, M.C., Gottlieb, M. & Menitove, J.E. (1992) Blood transfusion and postoperative infection in orthopedic patients. Transfusion, 32, 318-322.
9. Frietsch, T., Fessler, H., Kirschfink, M., Nebe, T., Waschke, K.F. & Lorentz, A. (2001a) Immune response to autologous transfusion in healthy volunteers: WB versus packed RBCs and FFP. Transfusion, 41, 470-476.
10. Frietsch, T., Krombholz, K., Tolksdorf, B., Nebe, T., Segiet, W. & Lorentz, A. (2001b) Cellular immune response to autologous blood transfusion in hip arthroplasty: whole blood versus buffy coat-poor packed red cells and fresh-frozen plasma. Vox Sanguinis, 81, 187-193.
11. Ghio, M., Contini, P., Mazzei, C., Merlo, A., Filaci, G., Setti, M., Indiveri, F. & Puppo, F. (2001) In vitro immunosuppressive activity of soluble HLA class I and Fas ligand molecules: do they play a role in autologous blood transfusion. Transfusion, 41, 988-996.
12. Hanssen, A.D. & Osmon, D.R. (1999) The use of prophylactic antimicrobial agents during and after hip arthroplasty. Clinical Orthopaedics and Related Research, 369, 124-138.
13. Innerhofer, P., Walleczek, C., Luz, G., Hobisch-Hagen, P., Benzer, A., Stöckl, B., Hessenberger, G., Nussbaumer, W. & Schobersberger, W. (1999) Transfusion of buffy coat-depleted blood components and risk of postoperative infection in orthopedic patients. Transfusion, 39, 625-632.
14. Karger, R. & Kretschmer, V. (1996) The importance of the quality of whole blood and red cell concentrates for autologous transfusion. A literature survey and meta-analysis of in vivo red cell recovery. Anaesthesist, 45, 694-707 (German; English abstract).
15. Karger, R. & Kretschmer, V. (2000) Cost-effectiveness of autologous blood predonation. Transfusion Alternatives in Transfusion Medicine, 4, 15-20.
16. Koch, A., Bouges, S., Ziegler, S., Dinkel, H., Daures, J.P. & Victor, N. (1997) Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: update of previous meta-analyses. The British Journal of Surgery, 84, 750-759.
17. Koch, A., Ziegler, S., Breitschwerdt, H. & Victor, N. (2001) Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis: meta-analysis based on original patient data. Thrombosis Research, 102, 295-309.
18. Kruskall, M.S., Yomtovian, R., Dzik, W.H., Friedman, K.D. & Umlas, J. (1994) On improving the cost-effectiveness of autologous blood transfusion practices. Transfusion, 34, 259-264.
19. Llewelyn, C.A., Hewitt, P.E., Knight, R.S.G., Amar, K., Cousens, S., Mackenzie, J. & Will, R.G. (2004) Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet, 363, 417-421.
20. Mezrow, C.K., Bergstein, I. & Tartter, P.I. (1992) Post-operative infections following autologous and homologous blood transfusions. Transfusion, 32, 27-30.
21. Murphy, P., Heal, J.M. & Blumberg, N. (1991) Infection or suspected infection after hip replacement surgery with autologous or homologous blood transfusions. Transfusion, 31, 212-217.
22. Nielsen, H.J. (1998) Clinical impact of bioactive substances in blood components: implications for leukocyte filtration. Infusionstherapie und Transfusionsmedizin, 25, 296-304.
23. Nielsen, H.J. (2000) Influence on the immune system of homologous blood transfusion and autologous blood donation: impact on the routine clinical practice/differences in oncological and non-tumour surgery? Anästhesiologie Intensivmedizin Notfallmedizin Schmerztherapie, 35, 642-645.
24. Pocock, S.J. (1983) Clinical Trials. A Practical Approach. John Whiley & Sons, Chichester.
25. Tasaki, T., Tasaki, S., Gotoh, K., Satoh, S., Takadate, J., Tachibana, M. & Suwabe, A. (2003) The significance of prestorage leukoreduction of autologous blood. Transfusion, 43S, 113A.
26. Tolksdorf, B., Frietsch, T., Quintel, M., Kirschfink, M., Becker, P. & Lorentz, A. (2001) Humoral immune response to autologous blood transfusion in hip surgery: whole blood versus packed red cells and plasma. Vox Sanguinis, 81, 180-186.
27. Triulzi, D.J., Vanek, K., Ryan, D.H. & Blumberg, N. (1992) A clinical and immunologic study of blood transfusion and postoperative bacterial infection in spinal surgery. Transfusion, 32, 517-524.
28. Weisbach, V., Corbière, C., Strasser, E., Zingsem, J., Zimmermann, R. & Eckstein, R. (2001) The variability of compensatory erythropoiesis in repeated autologous blood donation, Transfusion, 41, 179-183.
29. Wymenga, A., van Horn, J., Theeuwes, A., Muytjens, H. & Slooff, T. (1992) Cefuroxime for prevention of post-operative coxitis. One versus three doses tested in a randomized multicenter study of 2,651 arthroplasties. Acta Orthopaedica Scandinavica, 63, 19-24.